VSee Health, Inc. (VSEEW) Revenue History
Annual and quarterly revenue from 2020 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
VSEEW Revenue Growth
Revenue Breakdown (FY 2024)
VSEEW's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
VSEEW Revenue Analysis (2020–2024)
As of May 8, 2026, VSee Health, Inc. (VSEEW) generated trailing twelve-month (TTM) revenue of $14.6 million, reflecting strong growth of +18.7% year-over-year. The most recent quarter (Q3 2025) recorded $4.0 million in revenue, up 17.4% sequentially.
Looking at the longer-term picture, VSEEW's historical revenue data shows a 3-year CAGR of +12.4%. The company achieved its highest annual revenue of $10.4 million in 2024, representing a new all-time high.
Revenue diversification analysis shows VSEEW's business is primarily driven by Subscription and Circulation (56%), Technology Service (27%), and Health Care, Patient Service (17%). With over half of revenue concentrated in Subscription and Circulation, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including TDOC (-1.5% YoY), AMWL (-30.3% YoY), and OPRX (+18.8% YoY), VSEEW has underperformed the peer group in terms of revenue growth. Compare VSEEW vs TDOC →
VSEEW Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| VSEEWCurrent | $15M | +18.7% | - | -596.4% | |
 TDOC | $2.5B | -1.5% | +18.3% | -10.4% | |
 AMWL | $249M | -30.3% | +0.3% | -42.2% | |
 OPRX | $109M | +18.8% | +20.4% | 10.7% | |
 TALK | $229M | +22.0% | +24.6% | 1.4% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% |
VSEEW Historical Revenue Data (2020–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $10.4M | +78.4% | $7.2M | 68.9% | $-62,150,845 | -596.4% |
| 2023 | $5.8M | -8.4% | $3.9M | 66.9% | $-1,471,950 | -25.2% |
| 2022 | $6.4M | -13.1% | $4.8M | 75.8% | $-3,594,970 | -56.4% |
| 2021 | $7.3M | +7.8% | $5.9M | 80.7% | $252K | 3.4% |
| 2020 | $6.8M | - | $5.5M | 80.3% | $404K | 5.9% |
See VSEEW's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VSEEW Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VSEEW vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVSEEW — Frequently Asked Questions
Quick answers to the most common questions about buying VSEEW stock.
Is VSEEW's revenue growth accelerating or slowing?
VSEEW revenue is accelerating at +18.7% year-over-year, exceeding the 5-year CAGR of N/A. TTM revenue reached $15M. Growth momentum has increased versus prior periods.
What is VSEEW's long-term revenue growth rate?
VSee Health, Inc.'s 5-year revenue CAGR of N/A reflects the sustained expansion pattern. Current YoY growth of +18.7% is above this long-term average.
How is VSEEW's revenue distributed by segment?
VSEEW reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2024 are available for download. Segment mix reveals concentration and diversification trends.